CAH Valuation

Cardinal Health Inc

Add to Watchlist

Advanced Chart

128.250

-2.200(-1.690%)

Overview
Forecast
Valuation

CAH Relative Valuation

CAH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CAH is overvalued; if below, it's undervalued.

Historical Valuation

Cardinal Health Inc (CAH) is now in the Overvalued zone, suggesting that its current forward PE ratio of 14.80 is considered Overvalued compared with the five-year average of 11.80. The fair price of Cardinal Health Inc (CAH) is between 87.57 to 118.26 according to relative valuation methord. Compared to the current price of 124.97 USD , Cardinal Health Inc is Overvalued By 5.67%.

Relative Value

Fair Zone

87.57-118.26

Current Price：124.97

5.67%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

-10.11

P/B

Median3y

-10.98

Median5y

-2.60

-1.60

FCF Yield

Median3y

11.14

Median5y

11.42

Competitors Valuation Multiple

The average P/S ratio for CAH's competitors is 0.49, providing a benchmark for relative valuation. Cardinal Health Inc Corp (CAH) exhibits a P/S ratio of 0.13, which is -73.68% above the industry average. Given its robust revenue growth of -3.79%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap